Paul O'Byrne, MD
McMaster University
9
8
9
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Gail Gauvreau, PhD
McMaster University
Shared therapeutic areas:
Worked with same sponsors:
Louis-Philippe Boulet, MD
Hopital Laval, Quebec
Shared therapeutic areas:
Worked with same sponsors:
Mark Fitzgerald, MD
Vancouver Coastal Health Research Institute
Shared therapeutic areas:
Worked with same sponsors:
Mark Fitzgerald, MD
University of British Columbia, Vancouver General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Gail M Gauveau, PhD
McMaster University
Shared therapeutic areas:
Worked with same sponsors:
Louis-Philippe Boulet, MD
IUCPQ, Institut de cardiologie et de pneumologie de l'Hôpital Laval
Shared therapeutic areas:
Worked with same sponsors:
Rene Pageau, M.Sc Pharm
Pharmaxis Ltd
Shared therapeutic areas:
Worked with same sponsors:
Richard Leigh, MD
University of Calgary
Shared therapeutic areas:
Worked with same sponsors:
Nikolaos Harokopos, MD
General hospital of Pyrgos, Peloponnese, Greece
Shared therapeutic areas:
Anastasios Palamidas, MD
Sotiria Pulmonary Hospital of Athens
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction
Effect of Ciclesonide on Exercise Induced Bronchoconstriction
The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics
Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics
Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?
Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma
A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
All 9 trials loaded